Hagino T, Onda M, Saeki H, Fujimoto E, et al. Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan. Eur J Dermatol 2024;34:525-532.
PMID: 39589036